2m 2m 2m 2m 2m 2m 2m
ENLIVEN THERP (ELVN)
NASDAQ
$48.59+$2.63 (+5.72%)
Price as of Jun 23, 2026 6:47 PM EDT- $3.2BMarket Cap
- 126.52%1-Year Change
- BiotechnologyIndustry
ENLIVEN THERP (ELVN)
$48.59+$2.63 (+5.72%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | N/A N/A | -4,000 -80.00% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 N/A | 0 N/A | 0 +100.00% | -4,000 -80.00% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -85.9M +6.29% | -80.8M +25.09% | -64.6M +240.94% | -18.9M -50.73% | |
Depreciation and Amortization Expense | 263,000 -17.03% | 317,000 +6.73% | 297,000 -51.39% | 611,000 +517.17% | |
Total Operating Expenses | 119.7M +14.45% | 104.6M +25.17% | 83.5M +143.74% | 34.3M -33.38% | |
Operating Profit | -119.7M +14.45% | -104.6M +25.17% | -83.5M -11,542.33% | 730,000 +101.42% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 16.0M +2.79% | 15.5M +30.01% | 11.9M +1,311.94% | 846,000 +1,358.62% | |
Income before Taxes | -119.7M +14.45% | -104.6M +25.17% | -83.5M -5,400.06% | 1.6M +103.06% | |
Income Taxes | 0 -100.00% | 232,000 N/A | 0 -100.00% | 88,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -103.7M +16.48% | -89.0M +24.36% | -71.6M -4,910.75% | 1.5M +102.90% | |
Net Income from Continuing Operations Applicable to Common | -103.7M +16.48% | -89.0M +24.36% | -71.6M -4,642.13% | 1.6M +103.07% | |
Basic EPS and Net Income | -1.83 -3.17% | -1.89 -5.97% | -2.01 -3,450.00% | 0.06 +102.53% | |
Diluted EPS and Net Income | -1.83 -3.17% | -1.89 -5.97% | -2.01 -3,450.00% | 0.06 +102.53% | |
Basic Weighted Average Shares | 56.7M +20.38% | 47.1M +32.43% | 35.5M +35.22% | 26.3M +21.36% | |
Diluted Weighted Average Shares | 56.7M +20.38% | 47.1M +32.43% | 35.5M +34.72% | 26.4M +21.81% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 98.9M -20.32% | 124.1M +23.94% | 100.1M +13.54% | 88.2M +82.57% | |
Short-Term Investments | 363.7M +92.12% | 189.3M +23.73% | 153.0M +264.57% | 42.0M 0.00% | |
Cash and Cash Equivalents and Short-Term Investments | 462.6M +47.59% | 313.4M +23.82% | 253.1M +94.48% | 130.2M +44.18% | |
Total Current Assets | 474.9M +49.27% | 318.1M +19.53% | 266.2M +196.92% | 89.6M -3.30% | |
Accumulated Depreciation | 229,000 -75.08% | 919,000 +36.96% | 671,000 -20.12% | 840,000 +266.81% | |
Property and Plant and Equipment and Net | 34,000 -92.58% | 458,000 -38.27% | 742,000 +196.80% | 250,000 0.00% | |
Total Long-Term Assets | 656,000 -90.86% | 7.2M +75.38% | 4.1M +76.11% | 2.3M +1,227.43% | |
Total Assets | 476.2M +46.17% | 325.8M +19.82% | 271.9M +195.64% | 92.0M -1.80% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 16.6M +4.10% | 15.9M -38.54% | 25.9M +1,314.97% | 1.8M -74.62% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 217,000 N/A | 0 -100.00% | 67,000 -83.50% | 406,000 -28.27% | |
Total Liabilities | 16.6M +4.10% | 15.9M -38.70% | 26.0M +1,318.63% | 1.8M -75.97% | |
Retained Earnings | -347.2M +42.59% | -243.5M +57.64% | -154.4M +5.78% | -146.0M -1.01% | |
Total Stockholders Equity | 459.6M +48.33% | 309.8M +26.00% | 245.9M +172.84% | 90.1M +4.76% | |
Total Shares Outstanding | 59.4M +21.46% | 48.9M +18.51% | 41.3M +57.08% | 26.3M 0.00% | |
Cash Flow | |||||
Cash from Operating Activities | -70.3M -3.95% | -73.2M +19.46% | -61.3M +72.26% | -35.6M -23.95% | |
Capital Expenditures | 158,000 +259.09% | 44,000 -70.47% | 149,000 -58.95% | 363,000 +2,925.00% | |
Cash from Investing Activities | -173.8M +382.93% | -36.0M -75.75% | -148.4M -293.96% | 76.5M +4,788.42% | |
Dividends Paid | 0 N/A | 0 N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 218.9M +64.36% | 133.2M -43.16% | 234.3M +19,101.30% | -1.2M -102.51% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | N/A N/A | N/A N/A | -18,250.00% -107.10% | |
Return on Assets | -25.86% -13.20% | -29.79% -24.29% | -39.35% -2,554.20% | 1.60% +102.88% | |
Return on Equity | -26.95% -15.87% | -32.04% -24.80% | -42.61% -2,621.91% | 1.69% +102.80% | |
Revenue Growth | N/A N/A | N/A N/A | N/A N/A | 80.00% +180.00% | |
Current Ratio | 28.66 +43.39% | 19.99 +94.47% | 10.28 -79.02% | 48.98 +280.98% | |
Cash Ratio | 5.97 -23.46% | 7.80 +101.66% | 3.87 -91.98% | 48.20 +619.31% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow